These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 16925996)
1. Antiallergic drugs, azelastine hydrochloride and epinastine hydrochloride, inhibit ongoing IgE secretion of rat IgE-producing hybridoma FE-3 cells. Hanashiro K; Sunagawa M; Tokeshi Y; Nakasone T; Ohta S; Nakamura M; Kosugi T Eur J Pharmacol; 2006 Oct; 547(1-3):174-83. PubMed ID: 16925996 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of IgE-mediated phosphorylation of FcepsilonRIgamma protein by antiallergic drugs in rat basophilic leukemia (RBL-2H3) cells: a novel action of antiallergic drugs. Hanashiro K; Sunagawa M; Nakasone T; Nakamura M; Kosugi T Int Immunopharmacol; 2007 Jul; 7(7):994-1002. PubMed ID: 17499203 [TBL] [Abstract][Full Text] [Related]
3. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs. Misawa M; Kanai Y Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697 [TBL] [Abstract][Full Text] [Related]
4. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells. Kempuraj D; Huang M; Kandere-Grzybowska K; Basu S; Boucher W; Letourneau R; Athanassiou A; Theoharides TC Int Arch Allergy Immunol; 2003 Nov; 132(3):231-9. PubMed ID: 14646384 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenic factor production from murine mast cells by an antiallergic agent (epinastine hydrochloride) in vitro. Asano K; Furuta A; Kanai K; Sakaue S; Suzaki H; Hisamitsu T Mediators Inflamm; 2008; 2008():265095. PubMed ID: 18725994 [TBL] [Abstract][Full Text] [Related]
6. Azelastine and suplatast shorten the distribution half-life of IgE in rats. Hanashiro K; Tokeshi Y; Nakasone T; Sunagawa M; Nakamura M; Kosugi T Mediators Inflamm; 2002 Feb; 11(1):61-4. PubMed ID: 11926596 [TBL] [Abstract][Full Text] [Related]
7. Sustained elevation of NF-kappaB DNA binding activity in radiation-induced lung damage in rats. Haase MG; Klawitter A; Geyer P; Alheit H; Baumann M; Kriegel TM; Kasper M; Baretton GB Int J Radiat Biol; 2003 Nov; 79(11):863-77. PubMed ID: 14698955 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of epinastine on superoxide generation by rat neutrophils. Fukuishi N; Kan T; Hirose K; Akagi R; Akagi M Jpn J Pharmacol; 1995 Aug; 68(4):449-52. PubMed ID: 8531420 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats. Tasaka K; Kamei C; Nakamura S Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of azelastine hydrochloride and suplatast tosilate on airway responses in sensitized rats following exposure to antigen. Hanashiro K; Tamaki N; Koga T; Nakamura M; Kinjoh K; Kosugi T Int J Tissue React; 1997; 19(3-4):163-9. PubMed ID: 9506318 [TBL] [Abstract][Full Text] [Related]
12. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha. Katsuyama K; Hirata Y J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558 [TBL] [Abstract][Full Text] [Related]
13. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages. Shin HM; Byung Hak Kim ; Eun Yong Chung ; Jung SH; Yeong Shik Kim ; Kyung Rak Min ; Kim Y Eur J Pharmacol; 2005 Oct; 521(1-3):1-8. PubMed ID: 16183054 [TBL] [Abstract][Full Text] [Related]
14. Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression. Roybal CN; Marmorstein LY; Vander Jagt DL; Abcouwer SF Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3973-9. PubMed ID: 16249470 [TBL] [Abstract][Full Text] [Related]
15. An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation. Aikawa Y; Yamamoto M; Yamamoto T; Morimoto K; Tanaka K Inflamm Res; 2002 Apr; 51(4):188-94. PubMed ID: 12058956 [TBL] [Abstract][Full Text] [Related]
16. NF-κB activation by peroxynitrite through IκBα-dependent phosphorylation versus nitration in colon cancer cells. Gochman E; Mahajna J; Reznick AZ Anticancer Res; 2011 May; 31(5):1607-17. PubMed ID: 21617217 [TBL] [Abstract][Full Text] [Related]
17. Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-kappaB in cultured caco-2 cells. Hershko DD; Robb BW; Wray CJ; Luo GJ; Hasselgren PO J Cell Biochem; 2004 Apr; 91(5):951-61. PubMed ID: 15034930 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factor-kappaB pathway. Li ZH; Tang QB; Wang J; Zhou L; Huang WL; Liu RY; Chen RF J Gastroenterol Hepatol; 2010 Jul; 25(7):1315-20. PubMed ID: 20594262 [TBL] [Abstract][Full Text] [Related]
19. Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells. Kempuraj D; Huang M; Kandere K; Boucher W; Letourneau R; Jeudy S; Fitzgerald K; Spear K; Athanasiou A; Theoharides TC Ann Allergy Asthma Immunol; 2002 May; 88(5):501-6. PubMed ID: 12027072 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Cohen-Lahav M; Shany S; Tobvin D; Chaimovitz C; Douvdevani A Nephrol Dial Transplant; 2006 Apr; 21(4):889-97. PubMed ID: 16455676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]